Current Surgical is developing a ‘smart’ needle designed to treat cancerous tumors
/
DateFeb 21 2023
D.C.-based Current Surgical this week announced a $3.2 million seed. The round, which brings the firm’s total raise up to $4 million, was led by... Read More →